FDA, CDC Committee Clash Over Nasal Spray Flu Vaccine Use
The U.S. Food and Drug Administration said Monday that it still believes the benefits of AstraZeneca's nasal flu vaccine outweigh any risks despite a Centers for Disease Control and Prevention advisory...To view the full article, register now.
Already a subscriber? Click here to view full article